DBV Technologies (DBVT) Interest Coverage Ratio (2020 - 2026)
DBV Technologies (DBVT) posted quarterly Interest Coverage Ratio of 5.69 for Q2 2026, down 26.12% year-on-year from 7.7 in Q2 2025, and up 15.73% on a QoQ basis from 6.75 in Q1 2026.
DBV Technologies (DBVT) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported Interest Coverage Ratio for 7 consecutive years, with 5.69 the latest figure, recorded in Q2 2026.
- Quarterly Interest Coverage Ratio fell 26.12% year-over-year to 5.69 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 19.98 (down 49.45% YoY) and the FY2025 annual result came in at 0.4, down 12.1% from the prior year.
- Interest Coverage Ratio climbed to 5.69 in Q2 2026 per DBVT's latest filing, from 6.75 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for DBVT reached as high as 271.15 in Q4 2024 and fell as low as 171.3 in Q4 2025.
- A 5-year average of 12.39 and a median of 12.94 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio surged 1342.0% — and 2025, when it slumped 163.17%.
- Year by year, Interest Coverage Ratio stood at 57.43 in 2022, then jumped by 61.98% to 21.83 in 2023, then jumped by 1342.0% to 271.15 in 2024, then plunged by 163.17% to 171.3 in 2025, then soared by 96.68% to 5.69 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 5.69, 6.75, and 171.3 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | -5.69 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.69 |
| Mar 31, 2026 | -6.75 |
| Dec 31, 2025 | -171.30 |
| Sep 30, 2025 | -3.80 |
| Jun 30, 2025 | -4.51 |
| Mar 31, 2025 | -3.07 |
| Dec 31, 2024 | 271.15 |
| Sep 30, 2024 | -3.34 |
| Jun 30, 2024 | -20.01 |
| Mar 31, 2024 | -14.96 |
| Dec 31, 2023 | -21.83 |
| Sep 30, 2023 | -10.20 |
| Jun 30, 2023 | -10.93 |
| Mar 31, 2023 | -42.67 |
| Dec 31, 2022 | -57.43 |
| Sep 30, 2022 | -24.55 |
| Jun 30, 2022 | -64.39 |
| Mar 31, 2022 | -28.77 |
| Dec 31, 2021 | -396.38 |
| Sep 30, 2021 | -31.73 |